Literature DB >> 10482635

Cell surface expression of biologically active influenza C virus HEF glycoprotein expressed from cDNA.

A Pekosz1, R A Lamb.   

Abstract

The hemagglutinin, esterase, and fusion (HEF) glycoprotein of influenza C virus possesses receptor binding, receptor destroying, and membrane fusion activities. The HEF cDNAs from influenza C/Ann Arbor/1/50 (HEF-AA) and influenza C/Taylor/1223/47 (HEF-Tay) viruses were cloned and expressed, and transport of HEF to the cell surface was monitored by susceptibility to cleavage by exogenous trypsin, indirect immunofluorescence microscopy, and flow cytometry. Previously it has been found in studies with the C/Johannesburg/1/66 strain of influenza C virus (HEF-JHB) that transport of HEF to the cell surface is severely inhibited, and it is thought that the short cytoplasmic tail, Arg-Thr-Lys, is involved in blocking HEF cell surface expression (F. Oeffner, H.-D. Klenk, and G. Herrler, J. Gen. Virol. 80:363-369, 1999). As the cytoplasmic tail amino acid sequences of HEF-AA and HEF-Tay are identical to that of HEF-JHB, the data indicate that cell surface expression of HEF-AA and HEF-Tay is not inhibited by this amino acid sequence. Furthermore, the abundant cell surface transport of HEF-AA and HEF-Tay indicates that their cell surface expression does not require coexpression of another viral protein. The HEF-AA and HEF-Tay HEF glycoproteins bound human erythrocytes, promoted membrane fusion in a low-pH and trypsin-dependent manner, and displayed esterase activity, indicating that the HEF glycoprotein alone mediates all three known functions at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482635      PMCID: PMC112902          DOI: 10.1128/JVI.73.10.8808-8812.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1).

Authors:  R A Lamb; C J Lai
Journal:  Virology       Date:  1982-12       Impact factor: 3.616

3.  A precursor glycoprotein in influenza C virus.

Authors:  G Herrler; R W Compans; H Meier-Ewert
Journal:  Virology       Date:  1979-11       Impact factor: 3.616

4.  The cytoplasmic tail of the influenza C virus glycoprotein HEF negatively affects transport to the cell surface.

Authors:  F Oeffner; H D Klenk; G Herrler
Journal:  J Gen Virol       Date:  1999-02       Impact factor: 3.891

5.  Structure of the influenza C glycoprotein gene as determined from cloned DNA.

Authors:  J B Pfeifer; R W Compans
Journal:  Virus Res       Date:  1984       Impact factor: 3.303

6.  Demonstration of hemolytic and fusion activities of influenza C virus.

Authors:  M Ohuchi; R Ohuchi; K Mifune
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

7.  Noncumulative sequence changes in the hemagglutinin genes of influenza C virus isolates.

Authors:  D A Buonagurio; S Nakada; U Desselberger; M Krystal; P Palese
Journal:  Virology       Date:  1985-10-30       Impact factor: 3.616

8.  Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene.

Authors:  M J Gething; J Sambrook
Journal:  Nature       Date:  1981-10-22       Impact factor: 49.962

9.  Isolation of influenza C virus recombinants.

Authors:  V R Racaniello; P Palese
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

10.  The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase.

Authors:  G Herrler; R Rott; H D Klenk; H P Müller; A K Shukla; R Schauer
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

View more
  8 in total

1.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

2.  Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.

Authors:  J Zhang; A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b.

Authors:  Andrew Pekosz; Scott R Schaecher; Michael S Diamond; Daved H Fremont; Amy C Sims; Ralph S Baric
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein.

Authors:  Christopher A Nelson; Andrew Pekosz; Chung A Lee; Michael S Diamond; Daved H Fremont
Journal:  Structure       Date:  2005-01       Impact factor: 5.006

Review 5.  Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses.

Authors:  Raoul J de Groot
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

Review 6.  Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus.

Authors:  Mingyang Wang; Michael Veit
Journal:  Protein Cell       Date:  2015-07-28       Impact factor: 14.870

Review 7.  Bitter-sweet symphony: glycan-lectin interactions in virus biology.

Authors:  Wander Van Breedam; Stefan Pöhlmann; Herman W Favoreel; Raoul J de Groot; Hans J Nauwynck
Journal:  FEMS Microbiol Rev       Date:  2013-12-06       Impact factor: 16.408

Review 8.  Epidemiology and Clinical Characteristics of Influenza C Virus.

Authors:  Bethany K Sederdahl; John V Williams
Journal:  Viruses       Date:  2020-01-13       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.